Nonetheless, acetylcholinesterase inhibitors, which remain the primary pharmacological agents for alleviating AD symptoms, have limited effects, and increasing the dosage or duration of treatment does not result in a dramatic cure for AD (Bohnen et al., 2005; Homma et al., 2016). Here, ACHE is linked to Alzheimer disease.